Biogen CEO to Step Down, Drugmaker Pulls Back on Alzheimer's Drug Aduhelm
Biogen Inc said on Tuesday that Chief Executive Michel Vounatsos will step down and that the company is ...
Stay updated with breaking news from Aduhelm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biogen Inc said on Tuesday that Chief Executive Michel Vounatsos will step down and that the company is ...
Biogen Inc said on Tuesday that Chief Executive Michel Vounatsos will step down and that the company is pulling back on selling its Alzheimer's drug Aduhelm after the U.S. government's Medicare... | May 3, 2022
The drug company will effectively give up on marketing Aduhelm, which comes with unproven benefits and serious safety risks.
Biogen will replace its CEO and largely abandon marketing of its controversial...
Biogen’s aducanumab, already hamstrung in the U.S. by a stifling coverage decision, won’t be hitting the European market anytime soon.